A simple diagnostic index comprising epithelial membrane antigen and fibronectin for hepatocellular carcinoma



Document title: A simple diagnostic index comprising epithelial membrane antigen and fibronectin for hepatocellular carcinoma
Journal: Annals of hepatology
Database: PERIÓDICA
System number: 000413461
ISSN: 1665-2681
Authors: 1
2
3
4
5
6
3
1
1
1
7
1
7
Institutions: 1Biotechnology Research Center, Research & Development Department, New Damietta. Egipto
2Mansoura University, Faculty of Science, Mansoura. Egipto
3Damietta University, Faculty of Science, New Damietta. Egipto
4Helwan University, Faculty of Science, El Cairo. Egipto
5Mansoura University, Faculty of Medicine, Mansoura. Egipto
6Mansoura University, Children’s Hospital, Mansoura. Egipto
7Delta University, Gamasa. Egipto
Year:
Season: Nov-Dic
Volumen: 14
Number: 6
Pages: 869-880
Country: México
Language: Inglés
Document type: Artículo
Approach: Analítico, descriptivo
English abstract Continuing search for suitable tumor-markers is of clinical value in managing patients with various malignancies. These markers may be presented as intracellular substances in tissues or may be released into the circulation and appear in serum. Therefore, this work is concerned with identification and quantitative determination of epithelial membrane antigen (EMA) and fibronectin and estimating their performances as surrogate markers for identifying hepatocellular carcinoma (HCC). Results. A total of 627 individuals constituted this study [fibrosis (F1-F3) = 217; cirrhosis = 191; HCC = 219]. Western-blot was used for identifying EMA and fibronectin in sera. As a result, a single immunoreactive band was shown at 130-kDa and 90-kDa corresponding to EMA and fibronectin, respectively. They were quantified using ELISA providing values in HCC higher than fibrosis or cirrhosis with a significant difference (P < 0.0001). For identifying HCC, EMA showed 0.82 area under receiver-operating characteristic curve (AUC) with sensitivity = 70% and specificity = 78% while fibronectin yielded AUC = 0.70 with sensitivity = 67% and specificity = 82%. FEBA-Test comprising fibronectin and EMA together with total-bilirubin and AFP was constructed yielding AUC = 0.92 for identifying HCC from cirrhosis with sensitivity = 89% and specificity = 85%. FEBA-Test was then tested for differentiating HCC from fibrosis showing AUC = 0.97 with sensitivity = 90% and specificity = 89%. FEBA-Test enabled the correct identification of HCC patients with CLIP 0-1 and size ≤ 3 cm with AUC = 0.80 and AUC = 0.84, respectively, indicating its ability in identifying early HCC. Conclusions. A four-marker index may improve the early detection of HCC with a high degree of accuracy
Disciplines: Medicina
Keyword: Diagnóstico,
Gastroenterología,
Oncología,
Carcinoma hepatocelular,
Marcadores tumorales,
Cirrosis hepática,
Fibrosis hepática,
Antígenos,
Membrana epitelial,
Fibronectina
Keyword: Medicine,
Diagnosis,
Gastroenterology,
Oncology,
Hepatocellular carcinoma,
Tumor markers,
Liver cirrhosis,
Liver fibrosis,
Antigens,
Epithelial membrane,
FIbronectin
Full text: Texto completo (Ver PDF)